These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J. Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049 [Abstract] [Full Text] [Related]
15. ACG clinical guideline: the diagnosis and management of focal liver lesions. Marrero JA, Ahn J, Rajender Reddy K, Americal College of Gastroenterology. Am J Gastroenterol; 2014 Sep; 109(9):1328-47; quiz 1348. PubMed ID: 25135008 [Abstract] [Full Text] [Related]
16. Combined Hepatocellular-Cholangiocarcinoma in a Patient With Cirrhosis Due to Cholesteryl Ester Storage Disease. Castro Narro GE, Gamboa Domínguez A, Consuelo Sánchez A, Salazar Martínez A, Agramonte Hevia J, Cebolla JJ, Cuellar Mendoza ME, Díaz Hernández HA. Hepatology; 2019 Apr; 69(4):1838-1841. PubMed ID: 30372535 [No Abstract] [Full Text] [Related]
17. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand. Smanadhikorn P, Pongpaew P, Srivatanakul P, Tungtrongchitr R, Supanaranond W, Schelp FP, Migasena P. Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052 [Abstract] [Full Text] [Related]
18. [What can be done for patients with cancer of the digestive tract in 2003? Guidelines of the Francophone Federation of Digestive Tract Cancerology--part II]. Conseil Scientifique de La FFCD. Gastroenterol Clin Biol; 2003 Jan; 27(1):43-58. PubMed ID: 12594364 [No Abstract] [Full Text] [Related]